Dietary intake of riboflavin is associated with health claims defined and evaluated for causality and level of evidence for the general population by the European Food Safety Authority (EFSA) 23 (Fig
Time assessment: If over 30 days since reconstitution, potency is likely compromised regardless of appearance
Relative contraindications: [1] Profound renal failure (may make repeat dosing confusing)
Treating p53 mutant aggregation-associated cancer
It is a synthetic 15-amino-acid peptide that has been studied for possible effects on tissue repair, inflammation, blood vessel formation, tendon and ligament models, gastrointestinal injury models, and wound-healing pathways
Statements Author contributions JW: Data curation, Formal Analysis, Methodology, Writing review & editing, Investigation, Conceptualization, Software, Writing original draft